SciSparc (SPRC) Share-based Compensation (2016 - 2018)
SciSparc (SPRC) posted Share-based Compensation of $96000.0 for Q4 2018, down 27.27% sequentially from $132000.0 in Q3 2018, and down 86.19% YoY from $695000.0 in Q4 2017.
SciSparc (SPRC) Share-based Compensation (2016 - 2018) Analysis & Trends
SciSparc has reported Share-based Compensation for 3 years, with the latest figure at $96000.0 in Q4 2018.
- Quarterly Share-based Compensation fell 86.19% year-over-year to $96000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $604000.0 (down 48.73% YoY) and the FY2025 annual result came in at $867000.0, up 52.37% from the prior year.
- Share-based Compensation declined to $96000.0 in Q4 2018 per SPRC's latest filing, from $132000.0 in the prior quarter.
- Over five years, Share-based Compensation peaked at $4.6 million in Q3 2017 and troughed at -$229000.0 in Q3 2016.
- A 3-year average of $572272.7 and a median of $132000.0 in 2016 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2017 and 2018: Share-based Compensation soared 2113.1% in 2017, then tumbled 97.14% in 2018.
- Over 3 years, Share-based Compensation stood at $348000.0 in 2016, then surged by 99.71% to $695000.0 in 2017, then plunged by 86.19% to $96000.0 in 2018.
- According to Business Quant data, Share-based Compensation over the past three periods registered $96000.0, $132000.0, and $138000.0 for Q4 2018, Q3 2018, and Q2 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 86.63 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 41.25 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 28.05 Mn |
| 10 | SciSparc | 836,385.99 | 836,385.99 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 96,000.00 |
| Dec 31, 2018 | 96,000.00 |
| Sep 30, 2018 | 132,000.00 |
| Sep 30, 2018 | 132,000.00 |
| Jun 30, 2018 | 138,000.00 |
| Jun 30, 2018 | 138,000.00 |
| Mar 31, 2018 | 238,000.00 |
| Mar 31, 2018 | 238,000.00 |
| Dec 31, 2017 | 695,000.00 |
| Dec 31, 2017 | 695,000.00 |
| Sep 30, 2017 | 4.61 Mn |
| Sep 30, 2017 | 4.61 Mn |
| Jun 30, 2017 | 71,000.00 |
| Jun 30, 2017 | 71,000.00 |
| Mar 31, 2017 | 64,000.00 |
| Mar 31, 2017 | 64,000.00 |
| Dec 31, 2016 | 348,000.00 |
| Dec 31, 2016 | 348,000.00 |
| Sep 30, 2016 | -229,000.00 |
| Sep 30, 2016 | -229,000.00 |